|3.||Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
|5.||Cardiac Sudden Death (Sudden Cardiac Arrest)
|1.||Jing, Ling: 11 articles (01/2015 - 07/2008)|
|2.||Ren, Jun: 11 articles (01/2013 - 03/2003)|
|3.||Zhou, Li-jun: 8 articles (01/2012 - 07/2008)|
|4.||Li, Wei-min: 7 articles (01/2012 - 07/2008)|
|5.||Fernández-Solà, Joaquim: 6 articles (12/2013 - 01/2002)|
|6.||Sang, Ying: 5 articles (01/2012 - 01/2011)|
|7.||Song, Jian: 5 articles (01/2011 - 07/2008)|
|8.||Li, Shuang: 4 articles (01/2012 - 09/2008)|
|9.||Yuan, Lin: 4 articles (01/2012 - 01/2011)|
|10.||Sacanella, Emilio: 4 articles (09/2011 - 02/2002)|
|1.||Ethanol (Ethyl Alcohol)IBA
02/05/2002 - "In patients with alcoholic cardiomyopathy, both abstinence and controlled drinking of up to 60 g of ethanol per day (four standard drinks) were comparably effective in promoting improvement in cardiac function."
12/01/1998 - "Prospective observational study with 20 patients with alcoholic cardiomyopathy (ACM), 9 (45%) in functional class (FC) II and 11 (55%) in FC III, 16 (80%) men, mostly black (55%), from 35 to 56 (x = 45) years old, heavy alcohol users (> 80 g ethanol for 51 to 112 (x = 88) months. "
03/01/2003 - "Acute ethanol exposure depresses ventricular contractility and contributes to alcoholic cardiomyopathy in both men and women chronically consuming ethanol. "
11/01/2000 - "Long-standing ethanol consumption acts as a chronic cardiac stress and often leads to alcoholic cardiomyopathy. "
08/01/1996 - "Changes in cardiac signal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy."
|3.||Dopamine (Intropin)FDA LinkGeneric
|4.||2- amino- 3- cyano- 6- methyl- 5- (4- pyridyl)pyridineIBA
03/01/2015 - "The results of immunohistochemical studies of the sinoatrial node---???---(SAN) and the working myocardium in the patients presenting with alcoholic cardiomyopathy (ACMP) are presented. "
11/01/2004 - "Significance, of the weight and dimensions of heart as well as of fat dystrophy of cardiomyocytes and of the related detection methods is demonstrated for the diagnosis of alcoholic cardiomyopathy (ACMP). "
08/01/1989 - "The model experiment with rats was undertaken to assess a reversibility of alcoholic cardiomyopathy (ACMP). "
01/01/1981 - "A composite morpho-histo-biochemical and ultrastructural investigation of the myocardium of 50 subjects dying suddenly in the presence of alcoholic cardiomyopathy (ACMP) was carried out. "
09/01/2015 - "Immunohistochemical (IHC) methods and polymerase chain reaction (PCR) were employed to study the cases of death from alcoholic cardiomyopathy (ACMP) among the patients presenting with interstitial myocarditis who did not have this condition in their medical histories. "
01/01/2008 - "Recent studies indicate that low concentrations of acetaldehyde may function as the primary factor in alcoholic cardiomyopathy by disrupting Ca(2+) handling or disturbing cardiac excitation-contraction coupling. "
04/14/2009 - "These data strongly support the notion that acetaldehyde may be an essential contributor to the chronic development of alcoholic cardiomyopathy."
01/01/2007 - "These data revealed that enhanced acetaldehyde production may be detrimental whereas facilitated acetaldehyde breakdown may be beneficial to alcoholic cardiomyopathy, indicating a possible therapeutic target against acetaldehyde in alcoholic tissue damage."
01/01/2007 - "Acetaldehyde and alcoholic cardiomyopathy: lessons from the ADH and ALDH2 transgenic models."
02/01/2006 - "Our data are consistent with the notion of acetaldehyde as a contributor to alcoholic cardiomyopathy and implicate the therapeutic potential of ALDH2 enzyme in alcoholic complications."
01/01/1987 - "[Role of peroxisomal enzymes and lipid peroxidation in the pathogenesis of alcoholic cardiomyopathy]."
01/01/1986 - "Study of the activity of some myocardial enzymes in sudden death cases with alcoholic cardiomyopathy (ACMP) was made by quantitative histochemical methods. "
01/01/1988 - "1. In order to test the hypothesis that the alcoholic cardiomyopathy under partial catalase inhibition is associated with the activation of lipid peroxidation in cardiomyocytes (Panchenko et al., Experientia 43, 580-581, 1987), the effects of ethanol and catalase inhibitor 3-amino-1,2,4-triazole (aminotriazole) on rat heart and liver content of reduced glutathione and on the activity of enzymes related to peroxide metabolism: catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase and glucose-6-phosphate dehydrogenase were investigated. "
|7.||Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/01/2012 - "The aim of this study was to investigate the relationship between CYP2E1 activity and markers of oxidative stress and cardiac cell apoptosis during the development of alcoholic cardiomyopathy (ACM). "
01/01/2012 - "Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy."
01/01/2013 - "Taken together, these findings suggest that ethanol metabolism through CYP2E1 may contribute to the pathogenesis of alcoholic cardiomyopathy including myocardial contractile dysfunction, oxidative stress and apoptosis, possibly through activation of JNK and ASK-1 signaling."
|8.||Adrenergic Receptors (Adrenergic Receptor)IBA
01/01/1985 - "Immunomorphological and biochemical study of the myoglobin in the myocardium of 118 males at the age of from 30 to 55 years who died suddenly from coronary insufficiency, chronic pulmonary-cardiac insufficiency and from alcoholic cardiomyopathy in Magadan and Moscow is described. "
01/01/1985 - "Almost two-fold decrease of the myoglobin concentration in the left ventricle without its visible hypertrophy was observed in alcoholic cardiomyopathy, this may serve as a complementary test in the diagnosis of this disease."
|1.||Heart Transplantation (Grafting, Heart)
|2.||Transplantation (Transplant Recipients)
02/01/1996 - "The unfavorable early outcome of patients receiving hearts from alcoholic donors suggests the presence of a subclinical alcoholic cardiomyopathy before transplantation and poor tolerance of rejection episodes after transplantation. "
11/01/2006 - "Before transplantation, 45.0%, 17.5%, 17.5% and 7.5% of patients were classified as IDC, CHD, alcoholic cardiomyopathy and hypertrophic cardiomyopathy. "
|3.||Bed Rest (Bedrest)